Introduction
Turbovas EZ is a prescription medication that combines two active ingredients: Rosuvastatin and Ezetimibe. It is used to manage high cholesterol levels in adults.
Uses
Turbovas EZ is prescribed to patients with high cholesterol levels, specifically in cases where diet and exercise alone have not effectively reduced cholesterol levels. It is used to lower LDL (bad) cholesterol and triglycerides, while also increasing HDL (good) cholesterol levels.
Dosage and Administration
The dosage of Turbovas EZ should be determined by your healthcare provider based on your individual cholesterol levels and medical history. It is typically taken orally once daily, with or without food. Follow your healthcare provider’s instructions regarding the dosage and administration of this medication.
Mechanism of Action
Turbovas EZ combines two active ingredients that work together to lower cholesterol levels. Rosuvastatin belongs to a class of medications known as statins, which inhibit an enzyme in the liver responsible for producing cholesterol. This leads to a decrease in LDL cholesterol levels. Ezetimibe, on the other hand, works by reducing the absorption of cholesterol from the intestines, further contributing to the overall reduction of cholesterol levels.
Side Effects
Common side effects may include headache, muscle aches, stomach pain, and constipation. These side effects are usually mild and temporary. However, if you experience any serious side effects such as muscle weakness, yellowing of the skin or eyes, or signs of an allergic reaction (e.g., rash, itching, swelling), seek immediate medical attention.
Drug Interactions
Turbovas EZ may interact with other medications, including certain blood thinners, antifungal medications, and certain antibiotics. Inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, and herbal products, to avoid potential interactions. Your healthcare provider can determine if any adjustments to your medication regimen are necessary.
Precautions
Before taking Turbovas EZ, inform your healthcare provider about any medical conditions you have, especially liver disease or kidney disease. Additionally, let your healthcare provider know if you are pregnant, planning to become pregnant, or breastfeeding, as the safety of this medication during pregnancy and breastfeeding has not been established. Turbovas EZ should not be used in patients with active liver disease or unexplained persistent elevations in liver function tests.
Storage
Turbovas EZ should be stored at room temperature, away from moisture and heat. Keep the medication in its original packaging and out of reach of children.
Patient Tips
- Follow your healthcare provider’s instructions regarding the dosage and administration of Turbovas EZ.
- It may take several weeks for this medication to have a noticeable effect on your cholesterol levels, so be patient and continue taking it as directed.
- Make sure to attend regular check-ups with your healthcare provider to monitor your cholesterol levels and assess the effectiveness of the medication.
- Maintain a healthy lifestyle, including a balanced diet and regular exercise, as these factors can also contribute to managing cholesterol levels.
- If you have any questions or concerns about Turbovas EZ, do not hesitate to contact your healthcare provider for clarification or guidance.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Ezetimibe: a medicine used to treat high blood cholesterol (NHS UK) [Accessed 1 Jun. 2024] (online) Available at:
- Ezetimibe 10 mg tablets (Health Professionals SmPC) Available at:
- Ezetimibe (Drugs.com) [Accessed 2 Jun. 2024] (online) Available at:
- ezetimibe (RX) [Accessed 19 Jun. 2024] (online) Available at:
- Ezetimibe (MedlinePlus) [Accessed 3 Jun. 2024] (online) Available at:
- Lamb YN. Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia. Am J Cardiovasc Drugs. 2020 Aug;20(4):381-392. doi: 10.1007/s40256-020-00421-1. [Accessed 6 Jun. 2024] Available at:
Reviews
There are no reviews yet.